<DOC>
	<DOCNO>NCT00056498</DOCNO>
	<brief_summary>This study determine whether add drug risperidone ( RisperdalÂ® ) effective placebo treat schizophrenic patient take drug clozapine .</brief_summary>
	<brief_title>Risperidone Treatment Schizophrenia Patients Who Are Currently Taking Clozapine</brief_title>
	<detailed_description>Clozapine antipsychotic drug approve treatment resistant patient schizophrenia . However , 50 % patient treated clozapine fail respond continue exhibit clinically significant residual positive negative symptom cognitive impairment . An emerge trend treatment addition second antipsychotic drug . This study determine risperidone give adjunctive treatment effective placebo treat schizophrenic patient fail clozapine therapy . Participants randomly assign add either adjunctive risperidone placebo current clozapine treatment single , daily dose 16 week . Positive negative symptom , cognitive impairment , side effect treatment , anxiety , depression , hostility symptom , quality life assess . Neurological test , self administer questionnaire , interview use assess patient .</detailed_description>
	<mesh_term>Schizophrenia</mesh_term>
	<mesh_term>Clozapine</mesh_term>
	<mesh_term>Risperidone</mesh_term>
	<criteria>DSMIV criterion schizophrenia schizoaffective disorder Current clozapine treatment Moderate illness severity inadequate positive symptom response clozapine treatment 6 month period clozapine treatment document clozapine blood level great equal 350 ng/ml clozapine norclozapine blood level great equal 450 ng/ml Organic brain disorder Mental retardation Medical condition whose pathology treatment could alter presentation treatment schizophrenia significantly increase risk associate propose treatment protocol Pregnancy DSMIV criterion current alcohol substance dependence within last 6 month DSMIV criterion alcohol substance abuse within last month Previously receive adjunctive risperidone ( dose great equal 8 mg/day ) clozapine treatment great equal 6 week</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>June 2012</verification_date>
</DOC>